Invested in Growth Aluna has secured significant funding of $15.3 million in Series B, highlighting investor confidence and potential for scaling innovative respiratory management solutions. This indicates an opportunity to connect with the company as they expand their product offerings and market reach.

Expanding Market Presence Recent acquisition by Huma Therapeutics GmbH and strategic partnerships, such as with ModuleMD, demonstrate Aluna's focus on strengthening its market position within respiratory and connected health spaces, making it a prime candidate for collaborative sales efforts.

Tech-Driven Solutions Aluna’s combination of machine learning, mobile app integration, and connected spirometer technology positions it as a forward-looking provider focused on digital health. This creates opportunities to offer complementary tech solutions and integrations to enhance their platform.

Healthcare Collaborations The company’s partnerships with EHR providers and pulmonology specialists suggest a receptive environment for sales of interoperable healthcare tools, medical hardware, or specialized software aimed at optimizing respiratory care workflows.

Market Appeal With an active focus on respiratory health management and recent high-profile funding, Aluna is an attractive target for sales of medical devices, data analytics platforms, or patient engagement solutions tailored to chronic respiratory conditions.